HTEC Among Disruptive Tech ETFs
End-of-day Nov 16, 2026 · 25 Disruptive tech ETFs by 1Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.1% | −5.8% | +0.8% | +5.9% | +22.0% | +29.6% | +91.4% | −7.9% | +79.7% |
| Peer average | −2.5% | −3.3% | −4.1% | −5.6% | +4.4% | +5.7% | +72.1% | +8.3% | — |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
$23 of every $1,000 in HTEC is Grail
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GRALGrail | Healthcare | 2.34% | $233.84 | 22K | $2.5M |
| 2 | ISRGIntuitive Surgical | Healthcare | 2.32% | $232.30 | 5,708 | $2.5M |
| 3 | GKOSGlaukos | Healthcare | 2.27% | $226.63 | 10K | $2.5M |
| 4 | CDNACaredx | Healthcare | 2.24% | $224.47 | 31K | $2.4M |
| 5 | AXGNAxogen | Healthcare | 2.24% | $223.60 | 44K | $2.4M |
| 6 | MRNAModerna | Healthcare | 2.22% | $221.86 | 11K | $2.4M |
| 7 | TMOThermo Fisher Scientific | Healthcare | 2.19% | $219.00 | 3,409 | $2.4M |
| 8 | TEMTempus AI | Healthcare | 2.05% | $205.19 | 31K | $2.2M |
| 9 | PHIA.ASKoninklijke Philips | Healthcare | 2.03% | $203.47 | 73K | $2.2M |
| 10 | REGNRegeneron Pharmaceuticals | Healthcare | 2.03% | $203.29 | 2,319 | $2.2M |
| 11 | ADPTAdaptive Biotechnologies | Healthcare | 2.03% | $203.16 | 76K | $2.2M |
| 12 | SHL.DESiemens Healthineers AG | Healthcare | 2.02% | $202.28 | 45K | $2.2M |
| 13 | LIVNLivanova | Healthcare | 2.02% | $202.06 | 24K | $2.2M |
| 14 | EWEdwards Lifesciences | Healthcare | 1.99% | $198.87 | 20K | $2.2M |
| 15 | LONN.SWLonza Group AG | Healthcare | 1.98% | $197.86 | 2,714 | $2.2M |
of the $47.1B in 27 Disruptive tech ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GRAL | Grail | 2.34% |
| 2 | ISRG | Intuitive Surgical | 2.32% |
| 3 | GKOS | Glaukos | 2.27% |
| 4 | CDNA | Caredx | 2.24% |
| 5 | AXGN | Axogen | 2.24% |
| 6 | MRNA | Moderna | 2.22% |
| 7 | TMO | Thermo Fisher Scientific | 2.19% |
| 8 | TEM | Tempus AI | 2.05% |
| 9 | PHIA.AS | Koninklijke Philips | 2.03% |
| 10 | REGN | Regeneron Pharmaceuticals | 2.03% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 30, 2025 | Dec 31, 2025 | $0.35 |
| Dec 28, 2021 | Dec 31, 2021 | $0.0230 |